Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-052497
Filing Date
2025-04-09
Accepted
2025-04-09 16:04:19
Documents
61
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q neog-20250228.htm   iXBRL 10-Q 2457154
2 EX-31.1 neog-ex31_1.htm EX-31.1 15468
3 EX-31.2 neog-ex31_2.htm EX-31.2 15262
4 EX-32 neog-ex32.htm EX-32 12256
5 GRAPHIC img194654855_0.jpg GRAPHIC 646845
  Complete submission text file 0000950170-25-052497.txt   10591851

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250228.xsd EX-101.SCH 1195392
63 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250228_htm.xml XML 1767104
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 25825204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)